Global Buprenorphine Hydrochloride Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Buprenorphine Hydrochloride Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Buprenorphine Hydrochloride report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Buprenorphine Hydrochloride market is projected to reach US$ 158.3 million in 2034, increasing from US$ 138.5 million in 2022, with the CAGR of 1.9% during the period of 2024 to 2034. Demand from Analgesic and Opioid Antagonist are the major drivers for the industry.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Buprenorphine Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Segment by Type
Tablets
Injection
Analgesic
Opioid Antagonist
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Buprenorphine Hydrochloride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Buprenorphine Hydrochloride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Buprenorphine Hydrochloride industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Buprenorphine Hydrochloride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Buprenorphine Hydrochloride introduction, etc. Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Buprenorphine Hydrochloride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Buprenorphine Hydrochloride report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Buprenorphine Hydrochloride market is projected to reach US$ 158.3 million in 2034, increasing from US$ 138.5 million in 2022, with the CAGR of 1.9% during the period of 2024 to 2034. Demand from Analgesic and Opioid Antagonist are the major drivers for the industry.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Buprenorphine Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Segment by Type
Tablets
Injection
Segment by Application
Analgesic
Opioid Antagonist
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Buprenorphine Hydrochloride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Buprenorphine Hydrochloride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Buprenorphine Hydrochloride industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Buprenorphine Hydrochloride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Buprenorphine Hydrochloride introduction, etc. Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Buprenorphine Hydrochloride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices